KRASIM interacts with the Kirsten rat sarcoma viral oncogene homolog (KRAS) to reduce KRAS protein levels, thereby inhibiting the transmission of oncogenic signals in HCC cells. Here, KRAS is linked to hepatocellular carcinoma.